Rhythm

Peerbridge Health Unveils COR-INSIGHT Trial to Validate Revolutionary AI-Enabled Cardiac and Cardiopulmonary Diagnostics & Monitoring

Inexpensive wearable technology for diagnostics and monitoring has the power to transform cardiac care BRENTWOOD, Tenn., Jan. 9, 2025 /PRNewswire/ — Peerbridge Health has announced the launch of its landmark COR-INSIGHT Trial, which will validate the screening and diagnostic capabilities…

Anumana and AliveCor Collaborate to Advance ECG-AI Algorithms for Early Detection of Cardiac Diseases on Kardia Devices

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Anumana, a leading AI-driven health technology company, today announced a collaboration with AliveCor to develop Anumana’s advanced AI algorithms for early cardiac disease detection on AliveCor’s Kardia electrocardiogram (ECG) devices, starting with Anumana’s FDA-cleared algorithm, ECG-AI™ LEF. “This collaboration demonstrates Anumana’s commitment to harnessing the potential of AI to expand […]

AccurKardia Receives FDA Breakthrough Device Designation for AI-powered Hyperkalemia Detection Solution Using Lead I ECG Data

January 07, 2025 07:05 AM Eastern Standard Time NEW YORK–(BUSINESS WIRE)–AccurKardia, an innovator in ECG-based diagnostics technology, has announced that it has received Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its ECG-based, AI-powered AK+ Guard™ hyperkalemia detection software. The investigational technology uses Lead I ECG data […]

Novel Heart Failure Technology from Alleviant Medical Gains FDA Approval for New Pivotal Trial and Breakthrough Designation for Significant Patient Population

AUSTIN, Texas–(BUSINESS WIRE)–Alleviant Medical, Inc., a privately held medical device company pioneering a no-implant atrial shunt for heart failure, today announced two significant milestones from the U.S. Food and Drug Administration (FDA). The FDA has granted the company investigational device exemption (IDE) approval to begin a pivotal trial focused on […]

Worldwide Wearables First as Novosound Demonstrates Ultrasound Blood Pressure Monitoring at CES 2025

anuary 05, 2025 03:05 PM Eastern Standard Time GLASGOW, Scotland–(BUSINESS WIRE)–In what will be a worldwide wearables first, Novosound is set to demonstrate ultrasound blood pressure monitoring at CES 2025 in Las Vegas between 7th-10th January, with the company revealing how it has been able to achieve accuracy levels comparable to conventional electronic cuff […]

Lucia Health Guidelines Initiates Clinical Study Evaluating its Lucia Health Coach Generative AI Agent for Educating and Supporting Patients with Atrial Fibrillation

Pilot study testing innovative agent designed to provide guideline-concordant education believed to be the first clinical study to evaluate an AI Agent with actual AFib patients SAN DIEGO, Dec. 18, 2024 /PRNewswire/ — Lucia Health Guidelines announces the enrollment of the first eight…

CardioFocus Announces First Patients Treated with OptiShot™ Pulsed Field Ablation System

December 17, 2024 03:09 PM Eastern Standard Time MARLBOROUGH, Mass.–(BUSINESS WIRE)–CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrhythmias, today announced the first series of patients treated with the investigational OptiShot™ Pulsed Field Ablation (PFA) System for the treatment of paroxysmal atrial fibrillation as part […]